(Q38980710)

8 September 2017

title

A major event for new tuberculosis vaccines (English)

1 reference

8 September 2017

0 references

1

Christopher Dye

1 reference

8 September 2017

Paul E M Fine

2

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

381

1 reference

8 September 2017

issue

9871

1 reference

8 September 2017

page(s)

972-974

1 reference

A rational vaccine pipeline for tuberculosis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

Tuberculosis vaccines: beyond bacille Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

Age and the epidemiology and pathogenesis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

The Development and Impact of Tuberculosis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960137-3

7 January 2021

10.1016/S0140-6736(13)60137-3

Identifiers

DOI

1 reference

8 September 2017

1 reference